Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2007 1
2008 4
2009 3
2010 4
2011 5
2012 8
2013 16
2014 7
2015 5
2016 4
2017 4
2018 6
2019 11
2020 11
2021 7
2022 9
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
The fourth HIV epidemic.
Laborde-Balen G, Taverne B, Ndour CT, Kouanfack C, Peeters M, Ndoye I, Delaporte E. Laborde-Balen G, et al. Among authors: kouanfack c. Lancet Infect Dis. 2018 Apr;18(4):379-380. doi: 10.1016/S1473-3099(18)30167-1. Epub 2018 Mar 21. Lancet Infect Dis. 2018. PMID: 29582762 No abstract available.
Cryptococcal meningitis: A neglected NTD?
Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A. Molloy SF, et al. Among authors: kouanfack c. PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. eCollection 2017 Jun. PLoS Negl Trop Dis. 2017. PMID: 28662028 Free PMC article. No abstract available.
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS. Loyse A, et al. Among authors: kouanfack c. Lancet Infect Dis. 2019 Apr;19(4):e143-e147. doi: 10.1016/S1473-3099(18)30493-6. Epub 2018 Oct 18. Lancet Infect Dis. 2019. PMID: 30344084 Review.
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
Tovar Sanchez T, Mpoudi-Etame M, Kouanfack C, Delaporte E, Calmy A, Venter F, Sokhela S, Bosch B, Akpomiemie G, Tembo A, Pepperrell T, Simmons B, Casas CP, McCann K, Mirchandani M, Hill A. Tovar Sanchez T, et al. Among authors: kouanfack c. Front Reprod Health. 2023 Sep 18;5:1133556. doi: 10.3389/frph.2023.1133556. eCollection 2023. Front Reprod Health. 2023. PMID: 37791109 Free PMC article.
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.
NAMSAL ANRS 12313 Study Group; Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E. NAMSAL ANRS 12313 Study Group, et al. Among authors: kouanfack c. N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31339676 Clinical Trial.
Genetic diversity and microevolution in clinical Cryptococcus isolates from Cameroon.
Sephton-Clark P, Temfack E, Tenor JL, Toffaletti DL, Loyse A, Molloy SF, Perfect JR, Bicanic T, Harrison TS, Lortholary O, Kouanfack C, Cuomo CA. Sephton-Clark P, et al. Among authors: kouanfack c. Med Mycol. 2023 Dec 1;61(12):myad116. doi: 10.1093/mmy/myad116. Med Mycol. 2023. PMID: 37952096 Free PMC article.
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Mbouyap PR, Fokam J, Ngoufack Jagni Semengue E, Mossiang L, Takou D, Ambe Chenwi C, Nka AD, Dambaya B, Teto G, Angong Beloumou G, Djupsa Ndjeyep SC, Ka'e AC, Kouanfack C, Ndjolo A, Mbopi Keou FX. Mbouyap PR, et al. Among authors: kouanfack c. Medicine (Baltimore). 2023 Jun 2;102(22):e33897. doi: 10.1097/MD.0000000000033897. Medicine (Baltimore). 2023. PMID: 37266631 Free PMC article.
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team. Molloy SF, et al. Among authors: kouanfack c. N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922. N Engl J Med. 2018. PMID: 29539274 Free article. Clinical Trial.
APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.
Kabore NF, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, Eymard-Duvernay S, Zoungrana J, Semde A, Sawadogo AB, Koulla-Shiro S, Kouanfack C, Ngom-Gueye NF, Meda N, Winkler C, Limou S. Kabore NF, et al. Among authors: kouanfack c. Kidney Int Rep. 2021 Oct 16;7(3):483-493. doi: 10.1016/j.ekir.2021.10.009. eCollection 2022 Mar. Kidney Int Rep. 2021. PMID: 35257061 Free PMC article.
119 results